Medicine by the Numbers

From The NNT Group, these provide short, concise, evidence-based ratings of therapies, diagnostic tests, and risk assessments commonly used in family medicine. These rating are based on patient-important benefits and harms.

Oct 1, 2016 Issue
Rivaroxaban vs. Warfarin for Anticoagulation in Patients with Atrial Fibrillation Undergoing Ablation and Cardioversion
Studies showed that 433 patients needed to be treated with rivaroxaban to prevent one stroke and 629 patients needed to be treated with rivaroxaban to prevent one thromboembolic event. Read more.

Sep 1, 2016 Issue
Perioperative Beta Blockers
Studies show that 1 in 72 patients had a nonfatal myocardial infarction prevents while harm end points included nonfatal stroke, hypotension, and bradycardia. Find out more.

Aug 1, 2016 Issue
Acupuncture for Frequent Tension-Type Headaches
Studies show an NNT of 3 to have at least a 50% reduction of headache frequency compared with routine care. Want to know more?

Jul 1, 2016 Issue
Topical NSAIDs for Acute Musculoskeletal Pain in Adults
Studies show that patients had improved pain control with diclofenac gel, ketoprofen gel, and ibuprofen gel with no increase in local or systemic adverse events. See why.

Jun 1, 2016 Issue
Corticosteroids for Community-Acquired Pneumonia
Studies show that 1 in 20 patients avoided mechanical ventilation and 1 in 16 patients avoided ARDS; 1 in 29 patients developed hyperglycemia requiring treatment. Read more.

May 1, 2016 Issue
Ibuprofen for Treatment of Episodic Tension-Type Headaches
Studies show that 1 in 14 patients were parin-free at two hours and none experienced adverse events. Find out more.

Apr 1, 2016 Issue
Leukotriene Receptor Antagonists in the Treatment of Acute Asthma
Studies show there were no patient-important benefits and no hospital admissions were prevented. Want to know more?

Mar 1, 2016 Issue
Controlled Cord Traction During the Third Stage of Labor

Feb 1, 2016 Issue
Cyclobenzaprine in the Treatment of Low Back Pain
Studies show that 1 in 3 patients experiences global improvement in back pain symptoms at 10 days, while 1 in 4 patients experiences medication adverse effects. Read more.

Dec 1, 2015 Issue
Gabapentin for Chronic Neuropathic Pain
Studies show that 1 in 6 patients were helped with diabetic neuropathy and 1 in 8 were helped with postherpetic neuralgia. Find out more.

Pages: 1 2 Next

Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now